Psychotropic Medication Patterns Among Youth in Foster Care

@article{Zito2008PsychotropicMP,
  title={Psychotropic Medication Patterns Among Youth in Foster Care},
  author={Julie Magno Zito and Daniel J. Safer and Devadatta Sai and James F. Gardner and Diane Thomas and Phyllis Coombes and Melissa Dubowski and Maria Mendez-Lewis},
  journal={Pediatrics},
  year={2008},
  volume={121},
  pages={e157 - e163}
}
CONTEXT. Studies have revealed that youth in foster care covered by Medicaid insurance receive psychotropic medication at a rate >3 times that of Medicaid-insured youth who qualify by low family income. Systematic data on patterns of medication treatment, particularly concomitant drugs, for youth in foster care are limited. OBJECTIVE. The purpose of this work was to describe and quantify patterns of psychotropic monotherapy and concomitant therapy prescribed to a randomly selected, 1-month… Expand
Psychotropic Medication Patterns among Youth in Juvenile Justice
TLDR
The rate of psychotropic medicationuse was low, concomitant medication use was common, and ethnic/race differences in psychopharmacologic treatment were present in this sample of youths in post-adjudicatory secure facilities. Expand
Use of Psychotropic Medications Among Youth in Treatment Foster Care
TLDR
Youth with “questionable polypharmacy” were less likely than other youth on multiple medications to have a recent visit to a psychiatrist and more likely to receive psychosocial mental health services than youth not taking medication. Expand
Outpatient Psychotropic Medication Use in the US: A Comparison Based on Foster Care Status
TLDR
The conclusion that distinct sets of factors predict medication for the two groups was reinforced by results of multivariate analyses; foster care status moderates the association between medication receipt and only one of the correlates examined (gender). Expand
Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care☆ , ☆☆
TLDR
Estimating any antipsychotic use and psychotropic polypharmacy among children in foster care during the last decade and characterize interstate variation in these trends found no change in absolute rates. Expand
Psychotropic Medication Use and Perceptions of Medication Effects Among Transition-Age Foster Youth
TLDR
Examining the prevalence of psychotropic medication use over time, youths’ perceptions of the benefits of medication, and associations between medication use and behavioral health problems in transition-age foster youth concludes that most youth reported either a positive or neutral view of the relative benefits of using medications. Expand
Antipsychotic Treatment Among Youth in Foster Care
TLDR
Additional study is needed to assess the clinical rationale, safety, and outcomes of concomitant antipsychotic use among Medicaid-enrolled youth in foster care and to inform statewide policies for monitoring and oversight of antipsychotics use among youths in the foster care system. Expand
Investigating geographic variation in use of psychotropic medications among youth in child welfare.
TLDR
The link between child welfare environment and medication use suggests the influence of systemic, as opposed to clinical, causes of variation in medication use, which requires greater implementation of organizational processes governing quality of care for this highly vulnerable population. Expand
Rates of psychotropic medication use over time among youth in child welfare/child protective services.
TLDR
Examination of rates of psychotropic medication use over time among a national probability sample of youths involved with child welfare/child protective services (CW/CPS) in the National Survey of Child and Adolescent Well-Being (NSCAW) demonstrated complex relationships with group membership. Expand
Inter-class Concomitant Pharmacotherapy in Medicaid-Insured Youth Receiving Psychiatric Residential Treatment
TLDR
Findings support the practice of deprescribing and underscore the need for further research on the prevalence of concomitant pharmacotherapy in PRTFs. Expand
Foster youth and psychotropic treatment: Where next?
TLDR
A look at how foster youth are prescribed psychoactive substances, including polypharmacy (sometimes called concomitant prescription), and at the mounting and major responses by federal and state governments. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care.
TLDR
Multivariate logistic regression revealed that participants who received psychotropics, alone or in combination, were significantly more likely to be in state custody, male, and older than other participants and less likely to being African American or Hispanic. Expand
Psychotropic medication treatment patterns among school-aged children in foster care.
TLDR
Among those children who received a clinician diagnosis of a severe psychiatric disorder for which medication is an accepted component of care, boys were more likely to receive medication treatment than girls, and stimulants were the most common class of medication used in the past year. Expand
Concomitant psychotropic medication for youths.
TLDR
Substantive systematic evidence is needed to clarify this increasingly common, inadequately researched child psychopharmacologic practice. Expand
Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
TLDR
Among a cohort of Medicaid-enrolled youths with ADHD, co-existing psychiatric disorders and complex psychopharmacologic treatments were more common in the disabled and foster care groups than in the low-income group. Expand
Multiple psychotropic medication use for youths: a two-state comparison.
TLDR
Examination of multiple psychotropic use among youths enrolled in two U.S. mid-Atlantic state Medicaid and state Children's Health Insurance Programs found Stimulants with antidepressants, antipsychotics, or alpha-agonists were the most common combinations. Expand
Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
OBJECTIVE This study sought to determine the degree to which Medicaid eligibility categories modify disparities between black and white youths in the prevalence of psychotropic medication. METHODSExpand
Mental health services for youths in foster care and disabled youths.
TLDR
It was revealed that the prevalence of mental disorders among youths enrolled in foster care was twice that of youths receiving Supplemental Security Income (SSI) and nearly 15 times that of other youths receiving other types of aid. Expand
Concomitant pharmacotherapy among youths treated in routine psychiatric practice.
TLDR
With high rates of concomitant pharmacotherapy among children and adolescents in psychiatric care, additional research on efficacy and safety of this treatment strategy is necessary. Expand
New users of antipsychotic medications among children enrolled in TennCare.
TLDR
The proportion of TennCare children who became new users of antipsychotics nearly doubled from 1996 to 2001, with a substantial increase in use of antippsychotics for attention-deficit/hyperactivity disorder, conduct disorder, and affective disorders. Expand
Use of mental health services among older youths in foster care.
TLDR
The child welfare system was actively engaged in arranging mental health services for youths in the foster care system, but the system was unable to maintain many youths in less restrictive living situations. Expand
...
1
2
3
4
...